SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C ...
Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. Unlearn uses recent developments from deep learning to create digital twins of ...
Before I went through personal development, I was closed-minded. Negative. Jealous. Thought I knew better. I thought that successful people were just lucky. That I was born less privileged than the ...
(Reuters) - Unlearn.AI, which has built a machine learning platform that creates "digital twin" profiles of patients in clinical trials, has raised $15 million to expand partnerships and accelerate ...
Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...
There’s something missing from the conversation about lifelong learning. Many of us already know we’ll need to absorb new knowledge and pick up new skills in order to stay competitive in the future ...
Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results